Treatment with oseltamivir in children hospitalized with community‐acquired, laboratory‐confirmed influenza: Review of five seasons and evaluation of an electronic reminder
- 19 March 2009
- journal article
- review article
- Published by Wiley in Journal of Hospital Medicine
- Vol. 4 (3), 171-178
- https://doi.org/10.1002/jhm.431
Abstract
BACKGROUND: When initiated within 48 hours of the onset of symptoms, oseltamivir has been shown to reduce severity and length of influenza illness. Few studies have evaluated the use of oseltamivir in patients hospitalized with influenza. OBJECTIVE: To describe the prescribing practices for oseltamivir in children hospitalized with influenza and to evaluate a mechanism to improve the rate of appropriate prescription. DESIGN, SETTING, PATIENTS: Retrospective cohort study of 929 patients aged 21 years or younger hospitalized with community‐acquired laboratory‐confirmed influenza (CA‐LCI) during 5 consecutive seasons (2000‐2005). We examined oseltamivir eligibility, which included patients 1 year of age or older with an influenza test result available within 48 hours of symptom onset. During the 2005‐2006 season, an observational trial of an electronic reminder was conducted to improve the frequency of oseltamivir prescription. MEASUREMENTS: Oseltamivir prescription. RESULTS: Of 305 patients (32.8%) eligible for treatment with oseltamivir, 49 (16.1% of those eligible) were prescribed oseltamivir during hospitalization. Prescription rates for indications consistent with the US Food and Drug Administration (FDA) approval (“on label”) increased from 0% to 37.2% over 5 seasons (P < 0.0001). Prescriptions outside this recommendation (“off label”) also increased over 5 seasons (P < 0.0001). Twenty‐nine (5%) of 624 patients were treated with oseltamivir off label; 11 were less than 1 year of age. Initiation of a reminder had no impact on prescription (P > 0.05). CONCLUSIONS: Oseltamivir was used infrequently for children hospitalized with influenza. In addition, use inconsistent with the FDA label of oseltamivir occurs. Mechanisms are needed to improve appropriate prescription of oseltamivir. Journal of Hospital Medicine 2009;4:171–178. © 2009 Society of Hospital Medicine.Keywords
This publication has 13 references indexed in Scilit:
- Off-label Drug Use in Hospitalized ChildrenArchives of Pediatrics & Adolescent Medicine, 2007
- Surveillance for Influenza Admissions Among Children Hospitalized in Canadian Immunization Monitoring Program Active Centers, 2003–2004Pediatrics, 2006
- Symptomatic Predictors of Influenza Virus Positivity in Children during the Influenza SeasonClinical Infectious Diseases, 2006
- Multistate Surveillance for Laboratory-Confirmed, Influenza-Associated Hospitalizations in ChildrenThe Pediatric Infectious Disease Journal, 2006
- Effects of Local Variation, Specialty, and Beliefs on Antiviral Prescribing for InfluenzaClinical Infectious Diseases, 2006
- Neurological and Neuromuscular Disease as a Risk Factor for Respiratory Failure in Children Hospitalized With Influenza InfectionPublished by American Medical Association (AMA) ,2005
- Physician Knowledge and Perspectives Regarding Influenza and Influenza VaccinationHuman Vaccines, 2005
- Oral oseltamivir treatment of influenza in childrenThe Pediatric Infectious Disease Journal, 2001
- Influenza and the Rates of Hospitalization for Respiratory Disease among Infants and Young ChildrenNew England Journal of Medicine, 2000
- The Effect of Influenza on Hospitalizations, Outpatient Visits, and Courses of Antibiotics in ChildrenNew England Journal of Medicine, 2000